Systemic Markers of Lipid Peroxidation and Antioxidants in Patients with Nonalcoholic Fatty Liver Disease

Yesilova, Zeki; Yaman, Halil; Oktenli, Cagatay; Ozcan, Ayhan; Uygun, Ahmet; Cakir, Erdinc; Sanisoglu, S. Yavuz; Erdil, Ahmet; xFC;ksel#Ates, Y&; Aslan, Murat; Musabak, Ugur; Erbil, M. Kemal; Karaeren, Necmettin; Dagalp, Kemal
April 2005
American Journal of Gastroenterology;Apr2005, Vol. 100 Issue 4, p850
Academic Journal
OBJECTIVES: The aim of the present study was to examine the systemic parameters of oxidative stress and antioxidants in patients with nonalcoholic fatty liver disease and investigate the relationship between these parameters and clinical and biochemical outcomes.METHODS: Fifty-one male patients with nonalcoholic fatty liver disease (group I), 30 age-matched and body mass index (BMI)-matched healthy male subjects, and 30 age-matched male patients with chronic viral hepatitis (group II) were enrolled in the study.RESULTS: Increased systemic levels of malondialdehyde and depletion of antioxidants such as coenzyme Q10, CuZn-superoxide dismutase, and catalase activity were observed in group I. Coenzyme Q10 and CuZn-superoxide dismutase correlated negatively with increasing necroinflammatory activity and fibrosis. Body fat was negatively associated with plasma coenzyme Q10 levels, while an inverse association was found between plasma catalase levels and TG. However, LDL was positively associated with plasma malondialdehyde levels. CuZn-superoxide dismutase levels were negatively associated with glucose, insulin, and HOMA-IR. In addition, the levels of CuZn-superoxide dismutase correlated significantly in a negative manner with BMI.CONCLUSIONS: Our results concerning correlations suggest that disturbances in BMI, body fat, and lipid metabolism may contribute to altered oxidative status in NAFLD, and insulin resistance may be related to decreased antioxidants in NAFLD as well as products of lipid peroxidation. However, although our results suggest interesting correlations, this different mostly“weak” relationships must be taken with caution.(Am J Gastroenterol 2005;100:1–6)


Related Articles

  • Lifestyle changes associated with a new antioxidant formulation in non-alcoholic fatty liver disease: a case series. Abenavoli, Ludovico; Peta, Valentina; Milic, Natasa // Annals of Hepatology: Official Journal of the Mexican Associatio;Jan/Feb2015, Vol. 14 Issue 1, p121 

    Non-alcoholic fatty liver disease (NAFLD) is a relevant issue in public health owing to its epidemiological burden. It represents the most common chronic liver disease in the general population and is expected to increase in future as a result of an ageing population. The only currently...

  • Non-Alcoholic Fatty Liver Disease in the Metabolic Syndrome. Giuseppe Palasciano; Antonio Moschetta; Vincenzo O. Palmieri; Ignazio Grattagliano; Gianluca Iacobellis; Piero Portincasa // Current Pharmaceutical Design;Jul2007, Vol. 13 Issue 21, p2193 

    Non-alcoholic fatty liver disease (NAFLD) is often associated with features of the metabolic syndrome, carrying an increased risk to develop non-alcoholic steatohepatitis (NASH), the inflammatory form of liver steatosis. Epidemiological data confirm that obesity, diabetes, hypertension and...

  • Liver Steatosis in Children With Chronic Hepatitis C. Guido, Maria; Bortolotti, Flavia; Jara, Paloma; Giacomelli, Luciano; Fassan, Matteo; Hierro, Loreto; Nebbia, Gabriella; Zancan, Lucia; Rugge, Massimo // American Journal of Gastroenterology;Nov2006, Vol. 101 Issue 11, p2611 

    OBJECTIVES: Steatosis is common in adults with chronic hepatitis C, and is involved in the progression of fibrosis. Because little is known about steatosis in pediatric hepatitis C, the aims of this study were to determine the prevalence and severity of steatosis in a pediatric population with...

  • Micronutrients-fortified rapeseed oil improves hepatic lipid accumulation and oxidative stress in rats fed a high-fat diet. Jiqu Xu; Xiaoqi Zhou; Hui Gao; Chang Chen; Qianchun Deng; Qingde Huang; Jing Ma; Zhengyang Wan; Jin'e Yang; Fenghong Huang // Lipids in Health & Disease;2012, Vol. 11 Issue 1, p1 

    Intake of high-fat diet is associated with increased fatty livers. Hepatic lipid accumulation and oxidative stress are key pathophysiological mechanisms in this disease. Micronutrients polyphenols, tocopherols and phytosterols in rapeseed exert potential benefit to hepatoprotection, but most of...

  • Can ESR be used to assess the levels of oxidative stress in fat-loaded human hepatocytes and hepatic stellate cells? Wetherill, Laura Faye // Bioscience Horizons: The National Undergraduate Research Journal;Jun2009, Vol. 2 Issue 2, p197 

    Non-alcoholic fatty liver disease (NAFLD) is a growing clinical problem, which manifests itself particularly in obese subjects who may have the metabolic syndrome. A two-hit hypothesis for the pathogenesis of the disease has been proposed. The first hit is the development of insulin resistance...

  • Preventive effects of chronic exogenous growth hormone levels on diet-induced hepatic steatosis in rats. Ying Qin; Ya-ping Tian // Lipids in Health & Disease;2010, Vol. 9, p78 

    Background: Non-alcoholic fatty liver disease (NAFLD), which is characterized by hepatic steatosis, can be reversed by early treatment. Several case reports have indicated that the administration of recombinant growth hormone (GH) could improve fatty liver in GH-deficient patients. Here, we...

  • Metabolic Therapy: Lessons from Liver Diseases. Garcia-Ruiz, Carmen; Marí, Montserrat; Colell, Anna; Morales, Albert; Fernandez-Checa, Jose C. // Current Pharmaceutical Design;12/1/2011, Vol. 17 Issue 35, p3933 

    Fatty liver disease is one of most prevalent metabolic liver diseases, which includes alcoholic (ASH) and nonalcoholic steatohepatitis (NASH). Its initial stage is characterized by fat accumulation in the liver, that can progress to steatohepatitis, a stage of the disease in which steatosis is...

  • Lipid Metabolism, Oxidative Stress and Cell Death Are Regulated by PKC Delta in a Dietary Model of Nonalcoholic Steatohepatitis. Greene, Michael W.; Burrington, Christine M.; Lynch, Darin T.; Davenport, Samantha K.; Johnson, Andrew K.; Horsman, Melissa J.; Chowdhry, Saleem; Zhang, Jian; Sparks, Janet D.; Tirrell, Paul C. // PLoS ONE;Jan2014, Vol. 9 Issue 1, p1 

    Steatosis, oxidative stress, and apoptosis underlie the development of nonalcoholic steatohepatitis (NASH). Protein kinase C delta (PKCδ) has been implicated in fatty liver disease and is activated in the methionine and choline-deficient (MCD) diet model of NASH, yet its pathophysiological...

  • Molecular Mechanisms and New Treatment Strategies for Non-Alcoholic Steatohepatitis (NASH). Takaki, Akinobu; Kawai, Daisuke; Yamamoto, Kazuhide // International Journal of Molecular Sciences;May2014, Vol. 15 Issue 5, p7352 

    Non-alcoholic steatohepatitis (NASH) is a severe form of non-alcoholic fatty liver disease (NAFLD), in which most patients exhibit non-progressive, non-alcoholic fatty liver (NAFL) attributable to simple steatosis. Multiple hits, including genetic differences, fat accumulation, insulin...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics